{"id":20284,"date":"2015-12-28T17:47:25","date_gmt":"2015-12-29T01:47:25","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2015\/12\/human-cloning-possible-but-unlikely-unless-medical-justification-can-be-found"},"modified":"2017-06-04T20:17:05","modified_gmt":"2017-06-05T03:17:05","slug":"human-cloning-possible-but-unlikely-unless-medical-justification-can-be-found","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2015\/12\/human-cloning-possible-but-unlikely-unless-medical-justification-can-be-found","title":{"rendered":"Human cloning possible but unlikely unless medical justification can be found"},"content":{"rendered":"<p><a class=\\'blog-photo\\' href=\"https:\/\/lifeboat.com\/blog.images\/human-cloning-possible-but-unlikely-unless-medical-justification-can-be-found.jpg\"><\/a><\/p>\n<p>A Chinese company building a massive animal cloning facility doesn\u2019t want to limit itself to just replicating cattle and pets but hopes to move into the human cloning business in the future. The company, Boyalife Group, possesses the technology to do so, its CEO, Xiaochun Xo, told AFP, but to date has been \u201cself-restrained\u201d because it fears public backlash.<\/p>\n<hr>\n<p>A Chinese company is claiming it has the technology to clone humans but is holding off because it says the public isn\u2019t ready. That\u2019s likely true, experts say, and it\u2019s not likely to change because there isn\u2019t a powerful enough medical reason that could swing public opinion.<\/p>\n<p><a href=\"http:\/\/www.cbc.ca\/news\/technology\/human-clone-ethics-debate-boyalife-group-animal-clone-centre-1.3369643\" target=\"_blank\">Read more<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Chinese company building a massive animal cloning facility doesn\u2019t want to limit itself to just replicating cattle and pets but hopes to move into the human cloning business in the future. The company, Boyalife Group, possesses the technology to do so, its CEO, Xiaochun Xo, told AFP, but to date has been \u201cself-restrained\u201d because [\u2026]<\/p>\n","protected":false},"author":384,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43],"tags":[],"class_list":["post-20284","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/20284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/384"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=20284"}],"version-history":[{"count":3,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/20284\/revisions"}],"predecessor-version":[{"id":68951,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/20284\/revisions\/68951"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=20284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=20284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=20284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}